Sbarra, Alyssa N.
Rolfe, Sam
Haeuser, Emily
Nguyen, Jason Q.
Adamu, Aishatu
Adeyinka, Daniel
Ajumobi, Olufemi
Akunna, Chisom
Amusa, Ganiyu
Dahiru, Tukur
Ekholuenetale, Michael
Esezobor, Christopher
Fowobaje, Kayode
Hay, Simon I.
Ibeneme, Charles
Ibitoye, Segun Emmanuel
Ilesanmi, Olayinka
Kayode, Gbenga
Krohn, Kris
Lim, Stephen S.
Medeiros, Lyla E.
Mohammed, Shafiu
Nwatah, Vincent
Okoro, Anselm
Olagunju, Andrew T.
Olusanya, Bolajoko O.
Osarenotor, Osayomwanbo
Owolabi, Mayowa
Pickering, Brandon
Sufiyan, Mu’awiyyah Babale
Uzochukwu, Benjamin
Walker, Ally
Mosser, Jonathan F.
Funding for this research was provided by:
Bill and Melinda Gates Foundation
Article History
Received: 13 May 2022
Accepted: 30 June 2023
First Online: 8 July 2023
Competing interests
: This study was funded by the Bill & Melinda Gates Foundation and Gavi, the Vaccine Alliance. The funders had no contribution to study design, data collection, data analysis, data interpretation, or writing of the manuscript. The corresponding author had full access to all data and results, as well as final responsibility for the decision to submit for publication. A.N.S., E.H., K.K., S.M., B.P., and J.F.M. report support from the Bill & Melinda Gates Foundation during the conduct of the study. Additionally, J.F.M. also reports support from Gavi, the Vaccine Alliance.